Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients

被引:19
|
作者
Johansen, Kirsten L.
Chertow, Glenn M.
机构
[1] San Francisco VA Med Ctr, Nephrol Sect, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA USA
关键词
D O I
10.1053/j.jrn.2007.06.005
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: Our objective was to determine the extent to which chronic kidney disease mineral bone disorder (CKD-MBD) is associated with health-related quality of life among incident dialysis patients. Design: This study's design was a cross-sectional analysis. Setting: This was part of the United States Renal Data System Dialysis Morbidity and Mortality Study (DMMS), Wave 2. Patients: The patients comprised 2590 adult participants in DMMS Wave 2, for whom quality of life and laboratory data were available. Methods: We stratified patients according to their serum concentrations of phosphorus, calcium, and parathyroid hormone (PTH), and compared health-related quality of life as a function of these indicators in analyses adjusted for demographic, clinical, and other laboratory variables. Main Outcome Measures: Main outcome measures included Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, and the Symptom score of the Kidney Disease Quality of Life. Results: Both high and low serum phosphorus concentrations were associated with lower PCS scores (-1.25 to -1.48 points compared with the reference category), as was low PTH (-1.49 points). Low serum phosphorus was associated with more severe symptoms of kidney disease (-3.88 points), but there were no associations between high phosphorus or either extreme of PTH and the Symptom score. Serum calcium concentration and the calcium x phosphorus product were unassociated with PCS or Symptom scores. There were no associations among phosphorus, calcium, or PTH and MCS. Analyses simultaneously controlling for serum phosphorus, calcium, and PTH showed similar results. Conclusion: High and low serum phosphorus and low PTH are associated with slightly poorer self-reported physical functioning. Clinical trials will be necessary to determine whether and to what extent improvement in health status may occur with the correction of selected disorders of mineral metabolism. (C) 2007 by the National Kidney Foundation, Inc.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 50 条
  • [21] Biomarkers and Health-Related Quality of Life in End-Stage Renal Disease: A Systematic Review
    Spiegel, Breman M. R.
    Melmed, Gil
    Robbins, Sean
    Esrailiant, Eric
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06): : 1759 - 1768
  • [22] Differences in health-related quality of life and treatment preferences among black and white patients with end-stage renal disease
    Hicks, LRS
    Cleary, PD
    Epstein, AM
    Ayanian, JZ
    [J]. QUALITY OF LIFE RESEARCH, 2004, 13 (06) : 1129 - 1137
  • [23] Differences in Health-Related Quality of Life and Treatment Preferences Among Black and White Patients with End-Stage Renal Disease
    LeRoi S. Hicks
    Paul D. Cleary
    Arnold M. Epstein
    John Z. Ayanian
    [J]. Quality of Life Research, 2004, 13 : 1129 - 1138
  • [24] Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
    Ming Pei
    Rute Aguiar
    Agneta A. Pagels
    Olof Heimbürger
    Peter Stenvinkel
    Peter Bárány
    Charlotte Medin
    Stefan H. Jacobson
    Britta Hylander
    Bengt Lindholm
    Abdul Rashid Qureshi
    [J]. BMC Nephrology, 20
  • [25] Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
    Pei, Ming
    Aguiar, Rute
    Pagels, Agneta A.
    Heimburger, Olof
    Stenvinkel, Peter
    Barany, Peter
    Medin, Charlotte
    Jacobson, Stefan H.
    Hylander, Britta
    Lindholm, Bengt
    Qureshi, Abdul Rashid
    [J]. BMC NEPHROLOGY, 2019, 20 (1)
  • [26] HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF ASIAN PATIENTS WITH END-STAGE RENAL DISEASE (ESRD) IN SINGAPORE
    Yang, F.
    Griva, K.
    Lau, T.
    Vathsala, A.
    Lee, E.
    Ng, H. J.
    Mooppil, N.
    Newman, S. P.
    Chia, K. S.
    Luo, N.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A471 - A471
  • [27] Perceived health and quality of life in chronic and end-stage kidney disease
    Legrand, Karine
    Speyer, E.
    Stengel, B.
    Frimat, L.
    Sime, W. Ngueyon
    Briancon, S.
    Ayav, C.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29
  • [28] Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease
    Tsai, Yi-Chun
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Wang, Shu-Li
    Hsiao, Shih-Ming
    Lin, Ming-Yen
    Kung, Lan-Fang
    Hsiao, Pei-Ni
    Chen, Hung-Chun
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1621 - 1626
  • [29] Quality of life in patients with chronic kidney disease: Focus on end-stage renal disease treated with hemodialysis
    Kimmel, PL
    Patel, SS
    [J]. SEMINARS IN NEPHROLOGY, 2006, 26 (01) : 68 - 79
  • [30] QUALITY-OF-LIFE AND PERSONS WITH END-STAGE RENAL-DISEASE
    CHUBON, RA
    [J]. DIALYSIS & TRANSPLANTATION, 1986, 15 (08) : 450 - 452